FNDC5 and type 2 diabetes mellitus: From a translational perspective, irisin represents both a biomarker for metabolic-neurocognitive deterioration and a therapeutic target, where lifestyle or dietary strategies aimed at sustaining irisin secretion may yield dual benefits in the prevention and management of OB and T2DM.